Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Vyant Bio, Inc. (VYNT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.9623+0.0423 (+4.60%)
At close: 04:00PM EST
0.9600 -0.00 (-0.24%)
After hours: 07:32PM EST
Advertisement
Full screen
Loading interactive chart...
  • Zacks Small Cap Research

    VYNT: Predicting Drug Discovery

    By John Vandermosten, CFA NASDAQ:VYNT READ THE FULL VYNT RESEARCH REPORT We are initiating coverage of Vyant Bio, Inc. (NASDAQ:VYNT) assigning a valuation of $2.00 per share. Vyant is a drug discovery and development technology company that is focusing on neurodevelopmental and neurodegenerative brain disorders. The company’s strategy for developing new therapies combines the application of

  • GlobeNewswire

    Vyant Bio Engages LifeSci Capital to Explore Strategic Alternatives

    CHERRY HILL, N.J., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’s proprietary central nervous system (“CNS”) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. Today, Vyant Bio announced that it has engaged LifeSci Capital as its financial adv

  • GlobeNewswire

    Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at Neuroscience 2022 Hosted by the Society for Neuroscience

    “Targeting specific functional rescue in a Rett patient cortical organoid disease model” CHERRY HILL, N.J., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’s proprietary central nervous system (“CNS”) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine lear

Advertisement
Advertisement